☆ 4.3 Editorial Material

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga

NUCLEIC ACID THERAPEUTICS (2017)

Journal

NUCLEIC ACID THERAPEUTICS

Volume 27, Issue 1, Pages 1-+

Publisher

MARY ANN LIEBERT, INC

DOI: 10.1089/nat.2016.0657

Keywords

regulatory; oligonucleotide; splicing modulation; therapy

Categories

Biochemistry & Molecular Biology Chemistry, Medicinal Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.